Our 2026 Milestone
Announcing a Strategic Partnership
Makyona Pharma is proud to announce its strategic partnership with Rightwin Pharma Solutions Inc, a professional pharmaceutical R&D platform based in China, designed to strengthen both companies’ R&D capabilities and establish a flagship cooperation model in Asia. This partnership brings together complementary strengths, international networks, and deep industry expertise to enhance pharmaceutical development, manufacturing, and market access capabilities. By combining resources and technical knowledge, we aim to deliver well-researched, robust, and efficient solutions that respond to evolving pharmaceutical needs worldwide. The collaboration also enables faster time-to-market, stronger cross-border partnerships, and entry into high-impact therapeutic areas, creating long-term value for our clients and partners globally.
Through this partnership, we aim to offer our clients a diverse and robust portfolio of pharmaceutical services that support and accelerate their visions:
🔹 Bridging Global Markets – Leveraging strong networks across Asia to enable faster market access and delivery of high-quality pharmaceutical products. With this we aim to leverage our joint network to cater to the growing demands in global markets with APIs, dossiers, formulations, new product developments and a variety of pharmaceutical specific services.
🔹 Shared Expertise & End-to-End Support – Combining technical, regulatory, and manufacturing expertise to support partners efficiently and compliantly. We look forward to supporting with consulting, formulation development, technology transfer and a host of other services that our clients may need.
🔹 Cross-Continent Partnerships – Creating structured cooperation models including joint ventures, licensing, and distribution partnerships to drive sustainable international growth.
🔹 Focus on Niche & High-Impact Segments – Expanding into specialized therapeutic areas such as anti-cancer, hormonal, and herbal solutions through pooled resources and R&D strengths. This expanded pool complements our existing specific expertise in OSD and Injectables.
Concluding the decision, leaders from both organizations emphasized the long-term value of the collaboration. “This partnership represents our milestone in strengthening cross-border pharmaceutical platform and expanding in to high-quality and niche sectors, delivering results to the evolving pharmaceutical sector.” said Mr. Khatua, from Makyona Pharma. Echoing this sentiment, Mr. Zuo, from Rightwin Pharma Solutions Inc, added, “By combining our expertise, networks, and shared goals of excellence, we are creating a strong future-proof platform for sustainable growth and impact across the international market.”